Literature DB >> 21645144

Platelet-derived growth factor and platelet-derived growth factor receptor-α expression in the normal human thymus and thymoma.

Anca Maria Cimpean1, Raluca Ceauşu, Svetlana Encică, Pusa Nela Gaje, Domenico Ribatti, Marius Raica.   

Abstract

Platelet-derived growth factor (PDGF) and its receptors (PDGFRs) are strongly involved in the normal development of several organs, tumour angiogenesis and malignant progression and metastasis. Few studies concerning their expression, distribution and role in normal and pathological human thymus are available in the literature. The aim of this study has been to analyse the immunohistochemical expression of PDGF and PDGFR-α in prenatal and postnatal normal human thymus and thymomal biopsy specimens. The results demonstrated immunoreactivity to both PDGF and PDGFR-α in all specimens, but the intensity, distribution and number of positive cells were different in normal thymus and thymomas, and also among different tumour types. PDGF and PDGFR-α were weakly expressed in foetal and postnatal humans with a different distribution between cortex and medulla in both blood vessels and epithelial cells, whereas they were overexpressed in thymoma, especially in type B2 and B3, in the tumour epithelial cells. Overall, these data suggest that PDGF and PDGFR-α may be involved in the pathophysiology of the human thymus.
© 2011 The Authors. International Journal of Experimental Pathology © 2011 International Journal of Experimental Pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645144      PMCID: PMC3193148          DOI: 10.1111/j.1365-2613.2011.00777.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  29 in total

1.  Structural heterogeneity and immunohistochemical profile of Hassall corpuscles in normal human thymus.

Authors:  Marius Raica; Svetlana Encică; Andrei Motoc; Anca Maria Cîmpean; Traian Scridon; Mircea Bârsan
Journal:  Ann Anat       Date:  2006-07       Impact factor: 2.698

2.  Dasatinib induces a response in malignant thymoma.

Authors:  Charles Chuah; Tse Hui Lim; Alvin Soon Tiong Lim; Sim Leng Tien; Chong Hee Lim; Richie Soong; Francis Lee; Yeh Ching Linn; Yeow Tee Goh; Foong Koon Cheah; Alwin Hwai Liang Loh
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

3.  Mesenchymal cells are required for functional development of thymic epithelial cells.

Authors:  Manami Itoi; Noriyuki Tsukamoto; Hisahiro Yoshida; Takashi Amagai
Journal:  Int Immunol       Date:  2007-07-11       Impact factor: 4.823

4.  Nerve growth factor stimulates proliferation, adhesion and thymopoietic cytokine expression in mouse thymic epithelial cells in vitro.

Authors:  Hee-Woo Lee; Yong-Jin Na; Pil-Ku Jung; Mi-Na Kim; Sung-Min Kim; Joo-Seop Chung; Bong-Seon Kim; Jae-Bong Kim; Jeon-Ok Moon; Sik Yoon
Journal:  Regul Pept       Date:  2008-01-16

Review 5.  Sorafenib for the treatment of advanced renal cell carcinoma.

Authors:  Robert C Kane; Ann T Farrell; Haleh Saber; Shenghui Tang; Gene Williams; Josephine M Jee; Chengyi Liang; Brian Booth; Nallaperumal Chidambaram; David Morse; Rajeshwari Sridhara; Patricia Garvey; Robert Justice; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

6.  Differential expression of NGF receptors in human thymic epithelial tumors.

Authors:  M Parrens; P Dubus; A Groppi; J F Velly; E Labouyrie; A de Mascarel; J P Merlio
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

7.  Contribution of neural crest-derived cells in the embryonic and adult thymus.

Authors:  Katie Foster; Julie Sheridan; Henrique Veiga-Fernandes; Kathleen Roderick; Vassilis Pachnis; Ralf Adams; Clare Blackburn; Dimitris Kioussis; Mark Coles
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

8.  Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus.

Authors:  Anca Maria Cimpean; Marius Raica; Svetlana Encica; Remus Cornea; Viorica Bocan
Journal:  Ann Anat       Date:  2008-02-01       Impact factor: 2.698

9.  PDGFRalpha-expressing mesenchyme regulates thymus growth and the availability of intrathymic niches.

Authors:  William E Jenkinson; Simona W Rossi; Sonia M Parnell; Eric J Jenkinson; Graham Anderson
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

10.  A PDGF receptor mutation in the mouse (Patch) perturbs the development of a non-neuronal subset of neural crest-derived cells.

Authors:  K Morrison-Graham; G C Schatteman; T Bork; D F Bowen-Pope; J A Weston
Journal:  Development       Date:  1992-05       Impact factor: 6.868

View more
  9 in total

Review 1.  PDGF: the nuts and bolts of signalling toolbox.

Authors:  Ammad Ahmad Farooqi; Salman Waseem; Asma M Riaz; Bilal Ahmed Dilawar; Shahzeray Mukhtar; Sehrish Minhaj; Makhdoom Saad Waseem; Suneel Daniel; Beenish Ali Malik; Ali Nawaz; Shahzad Bhatti
Journal:  Tumour Biol       Date:  2011-07-19

2.  Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.

Authors:  Anish Thomas; Arun Rajan; Arlene Berman; Yusuke Tomita; Christina Brzezniak; Min-Jung Lee; Sunmin Lee; Alexander Ling; Aaron J Spittler; Corey A Carter; Udayan Guha; Yisong Wang; Eva Szabo; Paul Meltzer; Seth M Steinberg; Jane B Trepel; Patrick J Loehrer; Giuseppe Giaccone
Journal:  Lancet Oncol       Date:  2015-01-13       Impact factor: 41.316

3.  Long lasting efficacy of sorafenib in a heavily pretreated patient with thymic carcinoma.

Authors:  Thomas Neuhaus; Joachim Luyken
Journal:  Target Oncol       Date:  2012-10-23       Impact factor: 4.493

4.  Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.

Authors:  Franz Enkner; Bettina Pichlhöfer; Alexandru Teodor Zaharie; Milica Krunic; Tina Maria Holper; Stefan Janik; Bernhard Moser; Karin Schlangen; Barbara Neudert; Karin Walter; Brigitte Migschitz; Leonhard Müllauer
Journal:  Pathol Oncol Res       Date:  2016-11-14       Impact factor: 3.201

5.  High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.

Authors:  Yngve Nordby; Elin Richardsen; Mehrdad Rakaee; Nora Ness; Tom Donnem; Hiten R H Patel; Lill-Tove Busund; Roy M Bremnes; Sigve Andersen
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

6.  Metastatic Thymic Carcinoma with Long Survival After Treatment with Sunitinib.

Authors:  Luis Cabezón-Gutiérrez; Parham Khosravi-Shahi; Sara Custodio-Cabello; Maria García-Martos; Magda Palka-Kotlowska; Ana Isabel Franco-Moreno
Journal:  Cureus       Date:  2018-07-14

7.  The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions.

Authors:  Rossana Berardi; Gaia Goteri; Silvia Pagliaretta; Vittorio Paolucci; Francesca Morgese; Alessandro Conti; Majed Refai; Cecilia Pompili; Claudia Duranti; Giulia Marcantognini; Agnese Savini; Miriam Caramanti; Silvia Rinaldi; Mariangela Torniai; Matteo Santoni; Antonio Zizzi; Paola Mazzanti; Azzurra Onofri; Giulia Ricci; Marina Scarpelli
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 2.895

Review 8.  Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.

Authors:  Kwaku Appiah-Kubi; Ying Wang; Hai Qian; Min Wu; Xiaoyuan Yao; Yan Wu; Yongchang Chen
Journal:  Tumour Biol       Date:  2016-05-19

9.  Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy.

Authors:  Rossana Berardi; Alessandro Brunelli; Silvia Pagliaretta; Vittorio Paolucci; Alessandro Conti; Gaia Goteri; Majed Refai; Cecilia Pompili; Giulia Marcantognini; Francesca Morgese; Zelmira Ballatore; Agnese Savini; Mariagrazia De Lisa; Miriam Caramanti; Matteo Santoni; Antonio Zizzi; Francesco Piva; Paola Mazzanti; Azzurra Onofri; Armando Sabbatini; Marina Scarpelli; Stefano Cascinu
Journal:  Oncotarget       Date:  2015-08-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.